Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

I would not be surprised if AVIPTADIL/ZYESAMI/RLF-100 corrects abnormalities in that gene.

Research by Dr. Ritchie Shoemaker has shown VIP corrects gene activation abnormalities in CIRS caused by exposure to water damaged buildings. Their research showed changes in genes controlling both ribosomes and mitochondria. Dr. Shoemaker has made testing for gene activity or suppression in relation to CIRS (ProgeneDx) availble at www.survivingmold.com.

Gene ID: 7432, updated on 29-Oct-2014, Also Known As: PHM27 The protein encoded by this gene (VIP) belongs to the glucagon family. Alternative splicing occurs at this locus and two transcript variants encoding distinct isoforms have been identified. GENE ID LINK

https://youarethehealer.org/mold-and-toxins/moldy-people/testing-for-mold-illness/vasoactive-intestinal-peptide/

But the FDA is slow walking/asking for more data on safe Zyesami while it warp speeds Big Pharma Remdesivir, Vaxx jabbers laced with nano particles and other preservatives.

https://rumble.com/vc9svf-nanoparticles-in-vaccines-and-neurological-harm.html